Laduviglusib trihydrochloride (CT99021 trihydrochloride) is a selective glycogen synthase kinase 3 (GSK-3) inhibitor with IC50s of 10 nM and 6.7 nM for GSK-3alpha and GSK-3beta. Laduviglusib trihydrochloride inhibits human GSK-3beta with a Ki of 9.8 nM. Laduviglus
Molecular Weight:
573.71
CAS Number:
[1782235-14-6]
Formula:
C22H20Cl5N8
Target:
Wnt/beta-catenin|||GSK-3
T22657
T22657
* VAT and and shipping costs not included. Errors and price changes excepted